STAT
NOVEMBER 6, 2024
The executive in charge of AstraZeneca operations in China is under detention by Chinese authorities who are investigating employees there, the company said. The disclosure comes after AstraZeneca last week acknowledged that Leon Wang, an executive vice president who also oversees international operations for the drugmaker, was being investigated along with a “small number” of employees.
PharmaVoice
NOVEMBER 6, 2024
After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 diabetes therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 6, 2024
Massachusetts voters on Tuesday rejected Question 4, the ballot measure that proposed decriminalizing the use of psychedelic substances for people older than 21 and allowing people to grow the hallucinogens at home. The AP projected the result in the early morning hours of Wednesday. The initiative proposed to decriminalize the use of five psychedelic compounds, most notably psilocybin , or so-called magic mushrooms, which can dramatically affect a person’s perceptions and thinking.
BioPharma Dive
NOVEMBER 6, 2024
Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 6, 2024
LONDON — Sales of Novo Nordisk’s obesity drug Wegovy jumped in the third quarter, the company said Wednesday as it reported quarterly profits that were in line with analyst expectations. Novo’s third quarter performance will be seen as a win for the company, particularly after Eli Lilly — its rival in the booming obesity drug market — reported earnings last week that fell below forecasts.
pharmaphorum
NOVEMBER 6, 2024
Two players in medical extended reality (XR) – XRHealth and NeuroReality – have come together in a quest to build the biggest company in the sector.Boston, US-based XRHealth is leading the deal, acquiring NeuroReality of the Netherlands for an undisclosed sum, combining their products and expertise in the use of XR and virtual reality software for healthcare applications.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
FDA Law Blog: Biosimilars
NOVEMBER 6, 2024
By Sara W. Koblitz — The fight between Jazz, Avadel, and FDA over narcolepsy drug sodium oxybate has been a long and arduous one. Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023.
STAT
NOVEMBER 6, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. Regardless of elections, we generally see the proverbial glass as half full. For those of you who worry the sky is falling, we will pass along something learned on Wall Street: “Sell sky.” After all, we have made it this far, so we are determined to hang on for another couple of days.
European Pharmaceutical Review
NOVEMBER 6, 2024
Dupixent (dupilumab) has been approved by the European Medicines Agency (EMA) as the first treatment for young children with eosinophilic esophagitis in the EU. This authorisation is based on Phase III data which found that 68 percent of children aged one to 11 years given Dupixent (dupilumab) achieved histological disease remission at 16 weeks. This result was maintained for up to one year.
STAT
NOVEMBER 6, 2024
No matter who wins the 2024 presidential race, one thing is clear: Political anxiety and division will remain high for the foreseeable future. So just before Election Day, I spoke with Kevin Smith, a professor of political science at the University of Nebraska who studies the intersection of political attitudes, biology, and evolution. In 2019, he and colleagues published a study that found almost 40% of Americans reported experiencing stress over politics, 11.5% thought their physical hea
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
NOVEMBER 6, 2024
Get the latest updates on progress with the UK's VPAG (Voluntary scheme for branded medicines Pricing, Access and Growth), including the latest recommendations from the National Institute for Health and Care Excellence (NICE).
STAT
NOVEMBER 6, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, major news this morning, so let’s get straight to it.
Pharmaceutical Technology
NOVEMBER 6, 2024
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.
Express Pharma
NOVEMBER 6, 2024
OmniActive Health Technologies (OmniActive) has announced its acquisition of ENovate Biolife (ENovate), a developer of clinically researched botanical ingredients. The transaction, financed through internal accruals, is expected to strengthen OmniActive’s position in delivering scientifically validated health ingredients to consumers worldwide. OmniActive, backed by TA Associates, has advanced encapsulation technologies to enhance ingredient solubility, stability, and bioavailability.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
NOVEMBER 6, 2024
Cassava Sciences is nearing a Phase 3 readout for its Alzheimer's drug, lecanemab, despite facing a scandal involving the SEC. Learn more about the latest updates on donanemab and the company's progress in the field of Alzheimer's research.
Express Pharma
NOVEMBER 6, 2024
Funding in the pharma and healthcare space decreased by 64.36 per cent in October 2024, amounting to $72 million, compared to $202 million raised in September 2024. Despite this decline, the October 2024 figure marked a slight increase of 5.26 per cent from the $68.4 million raised in October 2023. In terms of stagewise funding, early-stage and seed-stage rounds together accounted for approximately half of the total funding in October.
pharmaphorum
NOVEMBER 6, 2024
HCG’s drive to transform is motivated by industry-leading perspective on the emerging trend of “impact”, and recognition that understanding that the impact of medical communications efforts is more critical than ever.
Express Pharma
NOVEMBER 6, 2024
A recent study led by the Institute of Advanced Study in Science and Technology (IASST) in Guwahati has identified a protein, IL-35, that may offer a novel approach to diabetes treatment. The research highlights IL-35’s capacity to protect the immune system by reducing specific immune cells that release inflammatory chemicals, which are linked to pancreatic cell infiltration, a significant factor in type 1 and autoimmune diabetes mellitus.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
NOVEMBER 6, 2024
New results with Alligator's CD40 agonist mitazalimab show it nearly doubled survival in pancreatic cancer, ahead of phase 3 trial next year.
Express Pharma
NOVEMBER 6, 2024
In October 2024, the healthcare industry reported 102 deals valued at $8.9 billion, marking a 69 per cent decline in deal value compared to October 2023. According to GlobalData, this deal activity also fell short of the average over the past 12 months (October 2023 to September 2024), which recorded an average of 97 deals worth $17.5 billion. Three significant acquisitions contributed to 59 per cent of the total deal value in October 2024.
pharmaphorum
NOVEMBER 6, 2024
Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing results three months ago.
Outsourcing Pharma
NOVEMBER 6, 2024
As clinical trials evolve, electronic Clinical Outcome Assessments (eCOA) remain central to data quality but often lag in adoption due to complex setup and deployment challenges.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
NOVEMBER 6, 2024
Developing a Risk Management Plan (RMP) for generic drugs is a crucial step in ensuring the safety and efficacy of these medications. An RMP provides detailed information on a medicine’s safety profile, measures to prevent or minimize risks, and plans for ongoing safety monitoring and evaluation.
Pharma Times
NOVEMBER 6, 2024
New therapy targets specific genetic alterations, promises extended survival
FDA Law Blog: Biosimilars
NOVEMBER 6, 2024
By Jennifer D. Newberger — Though digital health is not new, it can still often be difficult to determine with precision the regulatory requirements applicable to a particular software product. Sometimes this is because FDA has not opined on a specific set of facts, but more often it is because FDA seems to take different approaches to the same technology offered by different companies.
Pharma Times
NOVEMBER 6, 2024
Phase 1 and 2 studies show promising results for anito-cel therapy
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Pharmacist
NOVEMBER 6, 2024
Pharmacists should talk to patients about benefits other than cost savings to help tackle medicines wastage, a pharmacy lead told a Public Policy Projects (PPP) conference in London yesterday. In particular, talking about the impact of medicines on climate change could help to engage patients in medicines optimisation, he suggested. Speaking at the PPP Integrated […] The post Discussing climate impact helps engage patients in medicines optimisation appeared first on The Pharmacist.
BioPharma Dive
NOVEMBER 6, 2024
Stephen Hoge will now oversee vaccine sales at Moderna, per a Bloomberg report. Elsewhere, Intra-Cellular unveiled an ambitious sales target and Syndax inked a lucrative royalty deal.
The Pharmacist
NOVEMBER 6, 2024
We caught up with the Pharmacist/Pharmacy Team of the Year Award shortlist ahead of this year’s General Practice Awards ceremony to be held on 6 December at the Novotel London West. The Chiswick Primary Care Network Pharmacy Team has established itself as a valuable part of the local healthcare landscape, demonstrating the value of pharmacy […] The post The GP Awards shortlist: Chiswick PCN Pharmacy Team appeared first on The Pharmacist.
World Pharma News
NOVEMBER 6, 2024
Professor Meritxell Huch receives this year's Otto Bayer Award. The Otto Bayer Award is presented alternating with the Hansen Family Award every second year. The award recognizes leading scientists working in German-speaking countries for ground-breaking research in chemistry or biochemistry. The award with a prize money of EUR 75,000 was generously established in 1984 by a provision in the will of Professor Otto Bayer, a former Director of Research at Bayer AG.
Pharmaceutical Commerce
NOVEMBER 6, 2024
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Delphine Perridy, chief commercial officer, Envirotainer, forecasts the future of the pharma cold chain regarding technological advancements and changes in market dynamics.
Expert insights. Personalized for you.
358 
Let's personalize your content